A new interim analysis from Ovation Fertility and Alife Health is exploring the potential of artificial intelligence (AI) to improve embryo selection during in vitro fertilization (IVF) procedures. This innovative research, presented at the 80th ASRM Scientific Congress & Expo, focuses on the impact of AI-assisted embryo evaluation on ongoing pregnancy rates. 

In a recent study presented at the 80th ASRM Scientific Congress & Expo, researchers have successfully applied ultra-rapid warming (URW) to cleavage-stage embryos for the first time. Previously studied in blastocyst-stage embryos, this faster and more efficient thawing process has now shown similarly encouraging results in earlier-stage embryos, offering new possibilities for fertility treatments and lab procedures. 

Ovation Fertility's research team is set to present four groundbreaking abstracts at the 2024 American Society for Reproductive Medicine (ASRM) Scientific Congress & Expo, underscoring the organization's commitment to advancing in vitro fertilization (IVF) laboratory processes and reproductive technologies. 

Dr. Warikoo will oversee the Ovation Fertility Cincinnati laboratory as well as a new andrology lab set to open in February 2024.

Ovation Fertility teams are presenting three poster and two oral presentations at the 2023 ASRM Scientific Congress & Expo, which takes place in New Orleans, Louisiana, October 14-18, 2023.

Ovation Fertility scientists contributed to four abstracts accepted for poster presentations at the ESHRE® 39th Annual Meeting, June 25-28, 2023.

New location will provide FCLV patients in Southern Nevada with enhanced clinic capabilities and top-notch lab services provided by Ovation Fertility.

The combined corporate entity provides advanced fertility care through 90+ locations and 28 laboratories.

Ovation® Fertility teams are presenting six poster presentations at the 2022 ASRM Scientific Congress & Expo, which takes place in Anaheim, California, October 22-26, 2022. Additionally, several Ovation scientists are leading courses, workshops and roundtable discussions at the annual event, where top experts in reproductive medicine discuss the latest in reproductive care.

Ovation® Fertility has announced a new partnership with Genomic Prediction that will enhance and expand the genetic testing options available to hopeful parents.

Ovation® Fertility strives to bring infertility patients the joy of parenthood through innovative science. To reach even more hopeful parents around the United States, Ovation is proud to announce that Debbie Wells is the organization’s new national sales director. Her work will help bring Ovation’s state-of-the-art offerings and scientific advancements to even more infertility practices, supporting patients on their family-building journeys.

Ovation® Fertility continues to grow and expand its presence throughout the United States with a new location in the Northeast. The addition of Ovation Fertility Vermont allows the nation’s leading IVF and andrology services company to enter a new market, increasing patient access to fertility care in the Northeastern United States.

Ovation® Fertility has a new director who is ready to take the renowned Fertility Storage Solutions program to the next level. Stephanie Rampello will be taking the helm to oversee the talented professionals who help keep frozen reproductive materials, including eggs, sperm and embryos, safe for the patients who need them to start and grow their families.

Ovation® Fertility is proud to announce that Marty McGuirk will be joining the organization’s mergers and acquisitions team as the chief development officer. He will be joining the existing mergers and acquisitions team to help Ovation expand its footprint of IVF, andrology and genetics laboratories around the United States.

Khalied Kaskar, PhD, HCLD has joined Ovation^® Fertility as the laboratory director for the IVF labs in Austin and San Antonio as well as the andrology labs in New Braunfels, Round Rock and South Austin. This laboratory director’s wealth of assisted reproductive technology experience and global perspective on fertility care will allow Ovation to continue bringing the joy of parenthood through innovative science.

Ovation^® Fertility scientists were invited to share three pieces of research at the ESHRE virtual 38th Annual Meeting. The event, hosted by the European Society of Human Reproduction and Embryology, takes place in Milan, Italy, July 3-6, 2022.

Ovation® Fertility and AI company Presagen collaborated to develop a novel decentralized artificial intelligence (AI) learning model that enhances AI training while adhering to data privacy laws.

Ovation® Fertility has announced a new IVF and andrology laboratory location as part of its continued growth and expansion throughout the United States. Thanks to a combination of state-of-the-art equipment and utilization of best practices in assisted reproductive technology, Ovation Fertility Grand Rapids will allow Ovation to continue to bring the joy of parenthood through innovative science.

Ovation® Fertility is pleased to announce the appointment of Stephen Roland to the Ovation senior management team as regional market director, East. As a regional market director, Roland will work directly with lab directors and their teams to ensure that their activities align with Ovation’s business objectives. He will also work to develop strong relationships with Ovation partner and referring physicians and their teams, providing valuable feedback to help Ovation ensure that our services are a good fit for their needs.

Ovation® Fertility has relocated its operations headquarters from the Los Angeles area to its Nashville office.